Arcellx (ACLX) EBT Margin (2023 - 2025)
Arcellx's quarterly EBT Margin came in at 3511.0% in Q4 2025, down 321246.0% year-on-year from N/an in Q4 2024, and down 208.42% quarter-over-quarter from 1138.39% in Q3 2025.
Arcellx has reported EBT Margin for 3 years, with the latest figure at 3511.0% in Q4 2025.
- For the quarter ending Q4 2025, EBT Margin fell 321246.0% year-over-year to 3511.0%; the trailing twelve-month figure through Dec 2025 stood at 1027.08% (down 92955.0% YoY), and the FY2025 full-year result was 1026.95%, down 92941.0% from the prior year.
- EBT Margin for Q4 2025 stood at 3511.0%, down from 1138.39% in the prior quarter.
- The five-year high for EBT Margin was 32.41% in Q4 2023, with the low at 3511.0% in Q4 2025.
- Average EBT Margin over 3 years is 597.76%, with a median of 215.9% recorded in 2023.
- Year-over-year, EBT Margin surged 16452 bps in 2024 and tumbled 321246 bps in 2025.
- Tracing ACLX's EBT Margin over 3 years: stood at 32.41% in 2023, then tumbled by 1021 bps to 298.55% in 2024, then slumped by 1076 bps to 3511.0% in 2025.
- The last three EBT Margin figures came in at 3511.0% (Q4 2025), 1138.39% (Q3 2025), and 693.97% (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -6.40% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 41.95% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 23.05% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 18.99% |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - | -3,511.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3,511.00% |
| Sep 30, 2025 | -1,138.39% |
| Jun 30, 2025 | -693.97% |
| Mar 31, 2025 | -766.02% |
| Dec 31, 2024 | -298.55% |
| Sep 30, 2024 | -98.52% |
| Jun 30, 2024 | -98.09% |
| Mar 31, 2024 | -18.34% |
| Dec 31, 2023 | 32.41% |
| Sep 30, 2023 | -263.03% |
| Jun 30, 2023 | -168.76% |
| Mar 31, 2023 | -150.82% |